Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Dana, Daneshmand ^a   Zary, Nokhodian ^a   Peyman, Adibi ^b   Behrooz, Ataei ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DETENTION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRISON; PRISONER; SERODIAGNOSIS; AGE DISTRIBUTION; BISEXUALITY; COMORBIDITY; MALE HOMOSEXUALITY; MULTICENTER STUDY; RISK ASSESSMENT; STATISTICS; SUBSTANCE ABUSE;

HEPATITIS B VIRUS;

AGE DISTRIBUTION; BISEXUALITY; COMORBIDITY; HEPATITIS B; HOMOSEXUALITY, MALE; HUMANS; IRAN; MALE; PREVALENCE; PRISONERS; PRISONS; RISK ASSESSMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84878275310     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/735761     Document Type: Article

References (20)

1. Almasio P. L., Babudieri S., Barbarini G., Brunetto M., Conte D., Dentico P., Gaeta G. B., Leonardi C., Levrero M., Mazzotta F., Morrone A., Nosotti L., Prati D., Rapicetta M., Sagnelli E., Scotto G., Starnini G., Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis b and c in special population groups (migrants, intravenous drug users and prison inmates). Digestive and Liver Disease 2011 43 8 589 595 2-s2.0-79960369225 10.1016/j.dld.2010.12.004
2. Liaw Y. F., Chu C. M., Hepatitis B virus infection. The Lancet 2009 373 9663 582 592 2-s2.0-59749096640 10.1016/S0140-6736(09)60207-5
3. Scott R. M., Snitbhan R., Bancroft W. H., Experimental transmission of hepatitis B virus by semen and saliva. Journal of Infectious Diseases 1980 142 1 67 71 2-s2.0-0018940124 (Pubitemid 10035148)
4. Han L., Zhang H. W., Xie J. X., Zhang Q., Wang H. Y., Cao G. W., A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World Journal of Gastroenterology 2011 17 38 4321 4333
5. Estrada A. L., Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Reports 2002 117 1, supplement S126 S134 2-s2.0-0036429421 (Pubitemid 35351226)
6. Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E., Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health 1996 86 5 655 661 2-s2.0-0029867968 (Pubitemid 26145477)
7. Sofian M., Aghakhani A., Banifazl M., Azadmanesh K., Farazi A. A., McFarland W., Viral hepatitis and HIV infection among injection drug users in a central Iranian City. Journal of Addiction Medicine 2012 6 4 292 296
8. Poorolajal J., Majdzadeh R., Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of Research in Medical Sciences 2009 14 4 249 258 2-s2.0-70449730766
9. Tavakkoli H., Mir-Nasseri M. M., Poustchi H., Afshar P., Motalebi M. N., Mohammadkhani A., Malekzadeh R., Prevalence and risk factors of hepatitis B infection in injection drug users, Tehran (2001-2002). Hepatitis Monthly 2008 8 1 29 33 2-s2.0-44949188666 (Pubitemid 351802694)
10. Kassaian N., Adibi P., Kafashaian A., Yaran M., Nokhodian Z., Shoaei P., Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan. International Journal of Preventive Medicine 2012 3, supplement 1 S156 S161
11. Nelwan E. J., Van Crevel R., Alisjahbana B., Indrati A. K., Dwiyana R. F., Nuralam N., Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Tropical Medicine & International Health 2010 15 12 1491 1498
12. Stief A. C. F., Martins R. M. B., de Andrade S. M. O., Pompilio M. A., Fernandes S. M., Murat P. G., Mousquer G. J., Teles S. A., Camolez G. R., Francisco R. B. L., Motta-Castro A. R. C., Seroprevalence of hepatitis b virus infection and associated factors among prison inmates in state of mato grosso do sul, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2010 43 5 512 515 2-s2.0-78649524109
13. Long J., Allwright S., Barry J., Reynolds S. R., Thornton L., Bradley F., Parry J. V., Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. British Medical Journal 2001 323 7323 1209 1212 2-s2.0-0035944758 (Pubitemid 33097310)
14. Babudieri S., Longo B., Sarmati L., Starnini G., Dori L., Suligoi B., Carbonara S., Monarca R., Quercia G., Florenzano G., Novati S., Sardu A., Iovinella V., Casti A., Romano A., Uccella I., Maida I., Brunetti B., Mura M. S., Andreoni M., Rezza G., Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Journal of Medical Virology 2005 76 3 311 317 2-s2.0-20044367645 10.1002/jmv.20375 (Pubitemid 40770885)
15. Nokhodian Z., Yazdani M. R., Yaran M., Shoaei P., Mirian M., Ataei B., Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan, Iran. Hepatitis Monthly 2012 12 7 442 447
16. Kassaian N., Ataei B., Yaran M., Babak A., Shoaei P., Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: seroprevalence and associated factors. Hepatitis Monthly 2011 11 5 368 371 2-s2.0-79957631950
17. Mir-Nasseri M. M., Mohammadkhani A., Tavakkoli H., Ansari E., Poustchi H., Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepatitis Monthly 2011 11 1 19 22 2-s2.0-79956216405
18. Zamani S., Ichikawa S., Nassirimanesh B., Vazirian M., Ichikawa K., Gouya M. M., Afshar P., Ono-Kihara M., Ravari S. M., Kihara M., Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy 2007 18 5 359 363 2-s2.0-34548504809 10.1016/j.drugpo.2007.02.007 (Pubitemid 47374506)
19. Stark K., Bienzle U., Vonk R., Guggenmoos-Holzmann I., History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. International Journal of Epidemiology 1997 26 6 1359 1366 2-s2.0-0031435333 10.1093/ije/26.6.1359 (Pubitemid 28010456)
20. Adoga M. P., Banwat E. B., Forbi J. C., Nimzing L., Pam C. R., Gyar S. D., Agabi Y. A., Agwale S. M., Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. Journal of Infection in Developing Countries 2009 3 7 539 547 2-s2.0-73449093862